The oxazine derivative compound 1 decreased the DNA binding ability of NF–κB and NF–κB-dependent luciferase expression and IκBα phosphorylation in hepatocellular carcinoma (HCC) and HCT116 cells. This evidence concerns the gene NFKBIA and hepatocellular carcinoma.